Adherence to anticoagulation with atrial fibrillation is suboptimal and can lead to an increased risk of stroke. With this feasibility study, we want to evaluate if and under what circumstances MEMS can be used in real-life by community pharmacists to identify possible non-adherence.
Patients using Humira can use Health Beacon, a smart tool for managing their adherence. KAVA, APB & Abbvie have developed a pilot project that allows pharmacists to counsel patients on their adherence, using the Health Beacon.
An iPACT study has demonstrated that community pharmacists are ideally located to support awareness campaigns and early detection of AF. With this project, we want to further expand the scope of Belgian pharmacy practice in the prevention and detection of chronic diseases.